Sign in to view content

ENVISION Trial 24-Week Data: Phase 2 Study of UBX1325, a New Senolytic Agent for Patients With Wet AMD

Raj K. Maturi, MD

Video
Published 2023

Related

Presumed Silicone Oil Droplets
Rahul N. Khurana, MD, FASRS
Updates from the Field
2017
Defining and Addressing Wet AMD Non-responders
Rishi P. Singh, MD
Updates from the Field
2019
Wet AMD 4 Symposium
Annual Meeting Talks
2020

Category: AMD-Neovascular

See more